A study comparing the effects of a combination of paracetamol and ibuprofen with paracetamol alone or ibuprofen alone or placebo
Maxi-Analgesic Arthroscopy Study: A double-blind, placebo-controlled, randomised, parallel group comparison of the effects of Maxigesic (paracetamol 1000mg + ibuprofen 300mg per dose) versus its individual components in participants with moderate to severe pain from post arthrsocopy surgery of the knee.
AFT Pharmaceuticals Ltd.
295 participants
Oct 31, 2011
Interventional
Conditions
Summary
A Phase 3 study in dental pain has demonstrated efficacy for the fixed-dose combination compared with the individual components(Merry et al. 2010). However an additional model of acute pain is required to demonstrate consistent efficacy in acute pain as per EMEA guidelines required (EMEA/CPMP/EWP/612/00 21 November, 2002). The fixed dose combination has already been approved in New Zealand and is on the market for OTC use. Periodic Safety Update data from the NZ market and also the open –label phase of the Phase II Osteoarthritis study 12 month continuation phase data are available.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
A combination of Paracetamol 500mg + Ibuprofen 150mg per tablet, 2 tablets orally every 6 hours for 24 hours.
Locations(2)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12611000952943